Dr. Karen Yeates highlights innovative strategies to combat cervical cancer in Africa, emphasizing advances in vaccination, HPV testing, and AI-assisted screening. Cervical cancer, highly preventable yet prevalent in sub-Saharan Africa, claims over 76,000 lives annually. The WHO’s 2020 Global Strategy aims to eliminate cervical cancer by 2030, setting ambitious targets: 90% HPV vaccination coverage, 70% screening with high-performance tests, and 90% treatment access. Transitioning to primary HPV DNA testing enhances detection and allows self-sampling, increasing accessibility and reducing stigma. AI technologies show promise in standardizing cervical assessments, enabling precise risk stratification. The PAVE consortium explores integrating HPV extended genotyping and AI for effective screening. Despite progress, especially in vaccination rates, significant gaps remain in treatment access. Robust political commitment and tailored national strategies are vital to achieving WHO targets and making cervical cancer a historical health threat in Africa. Innovations in screening and prevention are key for transformative health outcomes.
Source link
Share
Read more